CMRA

Comera Life Sciences Holdings, Inc. CMRA

CMRA
Comera Life Sciences Holdings, Inc. SYVC
Synovics Pharmaceuticals, Inc. SNNAQ
Sienna Biopharmaceuticals, Inc. RBSH
Rebus Holdings, Inc. NLVVF
New Leaf Ventures Inc GBIM
GlobeImmune, Inc. TNGNQ
Tengion, Inc. FPMI
FluoroPharma Medical, Inc. NTII
Neurobiological Technologies, Inc. ANTH
Anthera Pharmaceuticals, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode CMRA SYVC SNNAQ RBSH NLVVF GBIM TNGNQ FPMI NTII ANTH
6M -50.00 % 0.00 % 0.00 % 0.00 % 0.00 % -80.00 % 900.00 % 100.00 % 0.00 % 0.00 %
YTD -50.00 % 0.00 % 0.00 % -50.00 % -97.84 % -50.00 % 900.00 % 100.00 % 0.00 % -50.00 %
1Y -50.00 % 0.00 % 0.00 % 0.00 % -96.77 % -50.00 % 900.00 % 100.00 % 0.00 % -50.00 %
3Y -99.99 % 0.00 % 0.00 % -98.73 % -99.91 % -85.71 % 9 900.00 % -86.67 % 0.00 % 0.00 %
5Y -100.00 % 0.00 % -98.44 % -99.98 % -99.96 % -99.97 % 9 900.00 % -94.44 % -93.33 % -99.54 %
10Y -100.00 % 0.00 % -100.00 % -100.00 % -99.98 % -100.00 % 9 900.00 % -99.93 % -99.44 % -100.00 %
From the beginning -100.00 % 0.00 % -100.00 % -100.00 % -99.98 % -100.00 % 9 900.00 % -99.98 % -100.00 % -100.00 %

Dividend

Neurobiological Technologies, Inc.